With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Epigenetic Regulation of T cell Activation and Immunotherapy||The Johns Hopkins University School of Medicine / Brian Ladle, MD, PhD||Young Investigator Grants||2013||Maryland|
|Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / David Langenau, PhD||Innovation Grants||2013||Massachusetts|
|Genetic Dissection of Trisomy 21-TMD Using Human Pluripotent Stem Cells||Boston Children's Hospital / Glenn MacLean||Young Investigator Grants||2013||Massachusetts|
|Investigating the Role of Circadian Rhythm in the Progression of Acute Myeloid Leukemia||Boston Children's Hospital / Samantha Morris, PhD||Young Investigator Grants||2013||Massachusetts|
|Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers||Dana-Farber Cancer Institute / Charles Roberts, MD, PhD||Innovation Grants||2013||Massachusetts|
|Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD||Innovation Grants||2013||Massachusetts|
|Multifunctional Nanomaterials for the Prevention of Radiotherapy's Side Effects and Childhood Cancers||Massachusetts General Hospital / Charalambos Kaittanis, PhD||Young Investigator Grants||2013||Massachusetts|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|
|The Role of Prmt1 in Osteosarcoma Initiation and Metastasis||Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD||Young Investigator Grants||2013||Massachusetts|
|Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21||Dana-Farber Cancer Institute / Andrew Lane, MD, PhD||Young Investigator Grants||2013||Massachusetts|